In the realm of immunological research, the study of central nervous system (CNS) pathways relies heavily on well-characterized animal models. One of the most significant tools for this purpose is the eae mog peptide. As someone who follows the latest developments in biochemical research materials, I have observed how these specific sequences, particularly the MOG35-55 variant, have become foundational for researchers investigating complex autoimmune processes.
The Significance of MOG35-55 in Research
The MOG peptide is derived from the Myelin Oligodendro Characterization of myelin oligodendrocyte glycoprotein (MOG cyte Glycoprotein, a structural protein found in the myelin sheath. When discussing EAE, which stands for Experimental Autoimmune Encephalomyelitis, the MOG-induced EAE model is widely regarded as the gold by Z Jiang·2009·Cited by 43—In this study, we induced i.v. tolerance to EAE by administration ofMOG35-55 peptideand determined the effect of this approach on intracellular signaling Read more standard for studying demyelinating conditions in a controlled laboratory setting.
The specific fragment, myelin oligodendrocyte glycoprotein (MOG 35-55), is frequently utilized because it consistently triggers a reproducible immune response. Whether you are sourcing a 25 mg vial or an Experimental Autoimmune Encephalomyelitis kit (EAE) SB-PEPTIDE offers anExperimental Autoimmune Encephalomyelitis kit (EAE) with MOG35-55 peptide. From 450€/0 for one kit. with MOG35-55 peptide, the p by N Murugesan·2012·Cited by 62—EAE was induced in mice by active immunization with MOG35-55 peptide(MEVGWYRSPFSRVVHLYRNGK), of murine origin (W. M. Keck Biotechnology Read more urity and sequence accuracy—typically MEVGWYRSPFSRVVHLYRNGK—are paramount to the integrity of the study.
Mechanisms of Induction
When investigating how EAE was evaluated by peptide immunization, researchers often focus on the interplay between the antigen and the host's immune system. It is well-documented that the MOG peptide can induce typical EAE, which often presents with ascending paralysis in murine subjects.
A common procedural detail involves the use of adjuvants. In many protocols, MOG peptides and CFA were injected into mice to facilitate the necessary immune priming. The amount of Complete Freund’s Adjuvant (CFA) is a critical variable that researchers must calibrate to ensure the induction is consistent. Furthermore, MOG-induced Experimental Autoimmune Encephalomyelitis studies have shown that EAE induction with MOG peptide is distinct from models using whole proteins, as the peptide-specific approach allows for more granular control over T-cell and B-cell epitope targeting.
Emerging Trends and Variations
Beyond the standard 35-55 sequence, other variants exist to address different research objectives:
* Human (hu)-MOG1–125 induced EAE: This involves a longer sequence and is o Experimental Autoimmune Encephalomyelitis Animal ften compared against the shorter peptide to study B-cell recognition of native proteins.
* OM-MOG: Recent literature suggests that OM-MOG treats MOG-EAE in a peptide-specific manner, highlighting the potential for using modified peptides to modulate established immune responses.
* MOGtag: This family of fusion proteins offers additional versatility for those looking to expand beyond simple peptide immunization.
Considerations for Model Reliability
When selecting EAE model induction peptides, it is essential to consider the source and the validated activity of the material. Reliable suppliers ensure that the MOG35-55, a peptide derived from the Myelin Oligodendrocyte Glycoprotein, is synthesized with high-performance liquid chromatography (HPLC) verification.
In my view, the success of any Experimental Autoimmune Encephalomyel Active induction of experimental autoimmune itis (EAE) study depends on the precision of the peptides used. Whether the study involves active immunization or the monitoring of CD4+ and CD8+ T-cell responses, the use of a standardized MOG35-55 peptide ensures that data remains comparable across different laboratories.
As the scientific community continues to refine these models, the focus remains on the specific epitope interactions that define these complex pathways. By maintaining strict protocols and using high-quality reagents, researchers can continue to advance our understanding of how these proteins influence the CNS environment.